Takeda Pharmaceutical Company Limited (TAK)

NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
$21.77+1.68%As of 2026-11-22 · USD
Last session low $21.74Last session high $22.07
52-week low $14.1652-week high $22.07
Market cap
$69.55B
Sector
Healthcare
P/E (TTM)
over 200x
Dividend yield
2.83%
Next earnings
2027-01-28

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)70.2In the overbought range (above 70)
MACD (12, 26, 9)0.55Below its signal line (0.56); histogram -0.01
Bollinger %B (20, 2)90%Inside the bands (20.03 to 21.96)
SMA 2020.99Price is 3.7% above
SMA 5019.72Price is 10.4% above
SMA 20017.88Price is 21.8% above
ATR (20)1.93% of priceAverage true range per day
52-week position96%In the upper part of the 14.16 to 22.07 range

About Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma-derived therapies, oncology, vaccines, and neuroscience.

Insider filings, 90 daysNo purchases and 4 sales (about $4.9M).
Latest fiscal yearEnded 2026-03-31: revenue of 4.51T JPY and an operating margin of 10.3%.
Next earnings reportExpected on 2027-01-28.

Also listed as 4502.T (Tokyo)

More in Drug Manufacturers - Specialty & Generic